TW200612900A - The use of therapeutic and preventive action of l-3-n-butylphthalide on dementia, involving alzheimer's disease and vascular dementia - Google Patents

The use of therapeutic and preventive action of l-3-n-butylphthalide on dementia, involving alzheimer's disease and vascular dementia

Info

Publication number
TW200612900A
TW200612900A TW093133023A TW93133023A TW200612900A TW 200612900 A TW200612900 A TW 200612900A TW 093133023 A TW093133023 A TW 093133023A TW 93133023 A TW93133023 A TW 93133023A TW 200612900 A TW200612900 A TW 200612900A
Authority
TW
Taiwan
Prior art keywords
dementia
therapeutic
disease
butylphthalide
preventive action
Prior art date
Application number
TW093133023A
Other languages
Chinese (zh)
Other versions
TWI419686B (en
Inventor
Yi-Pu Feng
Xiao-liang WANG
Ying Peng
Jing-Hua Yang
Original Assignee
Inst Materia Medica Cams
Zhongqi Pharmaceutical Technology Shijiazhuang Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Materia Medica Cams, Zhongqi Pharmaceutical Technology Shijiazhuang Co filed Critical Inst Materia Medica Cams
Priority to TW093133023A priority Critical patent/TWI419686B/en
Publication of TW200612900A publication Critical patent/TW200612900A/en
Application granted granted Critical
Publication of TWI419686B publication Critical patent/TWI419686B/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention discloses the use of therapeutic and preventive action of L-3-n-butylphthalides on dementia, involving alzheimer's disease and vascular dementia. The molecular formula is showed as follows.
TW093133023A 2004-10-29 2004-10-29 The use of therapeutic and preventive action of l-3-n-butylphthalide on dementia, involving alzheimer's disease and vascular dementia TWI419686B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW093133023A TWI419686B (en) 2004-10-29 2004-10-29 The use of therapeutic and preventive action of l-3-n-butylphthalide on dementia, involving alzheimer's disease and vascular dementia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW093133023A TWI419686B (en) 2004-10-29 2004-10-29 The use of therapeutic and preventive action of l-3-n-butylphthalide on dementia, involving alzheimer's disease and vascular dementia

Publications (2)

Publication Number Publication Date
TW200612900A true TW200612900A (en) 2006-05-01
TWI419686B TWI419686B (en) 2013-12-21

Family

ID=50158257

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093133023A TWI419686B (en) 2004-10-29 2004-10-29 The use of therapeutic and preventive action of l-3-n-butylphthalide on dementia, involving alzheimer's disease and vascular dementia

Country Status (1)

Country Link
TW (1) TWI419686B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1048158C (en) * 1993-09-09 2000-01-12 中国医学科学院药物研究所 Apiolin-A use in preparation of medicine for prevention and treatment of diseases caused by cerebral ischemia
DE4341202A1 (en) * 1993-12-03 1995-06-08 Zahnradfabrik Friedrichshafen Protection for a steering gear of a tracked vehicle

Also Published As

Publication number Publication date
TWI419686B (en) 2013-12-21

Similar Documents

Publication Publication Date Title
GB0223040D0 (en) Therapeutic compounds
GB0225475D0 (en) Therapeutic agents
HK1087398A1 (en) 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
GB0318447D0 (en) Therapeutic agents
EP1562897A4 (en) Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer s disease
EP1769791A3 (en) Treatment of Alzheimer's disease with cell cycle inhibitors
GB0223038D0 (en) Therapeutic compounds
SG149063A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
GB0108592D0 (en) Therapeutic agents
HK1092467A1 (en) N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses n-
WO2005004803A3 (en) Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease
WO2004062625A3 (en) Macrocyclic beta-secretase inhibitors for treatment of alzheimer's disease
GB0225474D0 (en) Therapeutic agents
WO2005004802A3 (en) N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease
WO2004006858A3 (en) Compounds, compositions, and methods employing same
IS8485A (en) Use of substituted 2-aminotetralins in the prevention of Parkinson's disease
BG108269A (en) Pyrazolopyrimidines as therapeutic agents
MXPA05012323A (en) Cyclic sulfonamides for inhibition of gamma-secretase.
WO2005018545A3 (en) Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease
WO2006050861A3 (en) Statine derivatives for the treatment of alzheimer's disease
WO2003106450A8 (en) Phenylaminopyrimidines and their use as rho-kinase inhibitors
DE60233350D1 (en) IMIDAZOi2,1-B -1,3,4-THIADIAZOLE SULFONAMIDES
MXPA05009986A (en) Ifn-beta alone or in combination with other medicaments for treating alzheimer's disease and demens disorders.
HK1104280A1 (en) Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseases
RS8504A (en) Novel cyclohexil sulphones